公研心理 · 心理学公共研习平台 定义 · 要点 · 来源
首页 / 研究速递 / 2026-10-31
Research digest · 研究速递

接受HAIC联合免疫治疗和靶向治疗的肝细胞癌患者的睡眠障碍和相关因素:一项横断面研究

Sleep Disturbance and Associated Factors in Hepatocellular Carcinoma Patients Receiving HAIC Combined with Immunotherapy and Targeted Therapy: A Cross-Sectional Study
Yanxia Huang、Shuyue Liu、Tiantian Wang · Cancer Management and Research · 2026-10-31

目的:本研究评估了肝细胞癌(HCC)患者接受肝动脉灌注化疗(HAIC)联合靶向治疗和免疫治疗的睡眠障碍患病率及相关因素。

研究信息

期刊 / 来源
Cancer Management and Research
发表日期
2026-10-31
文献库
OpenAlex
作者
Yanxia Huang, Shuyue Liu, Tiantian Wang
DOI
10.2147/cmar.s648657
读原文 ↗
英文原文摘要全文

Purpose: This study assessed the prevalence of sleep disturbance and associated factors in patients with hepatocellular carcinoma (HCC) receiving hepatic arterial infusion chemotherapy (HAIC) combined with targeted therapy and immunotherapy. Patients and Methods: A cross-sectional survey enrolled 230 patients undergoing HAIC combined with targeted therapy and immunotherapy at Sun Yat-sen University Cancer Center (July–November 2025). Sleep, psychological distress, pain, appetite, and quality of life were assessed using the PSQI, HADS, NRS, VAS, and EORTC QLQ-C30, respectively, along with prior

中文摘要由自动翻译整理,可能丢掉原文的限定条件;涉及具体数字与结论时以英文原文为准。

这条研究涉及的词条

同一天收录的其它研究

免责声明 公研心理仅为心理学学习、知识研习工具平台。平台内所有心理测评结果、心理学解读仅供学习与自我探索参考,不可作为精神疾病诊断依据,不能替代精神科医师、注册心理师的专业评估。若长期存在情绪困扰,请前往正规医疗机构或专业心理服务机构求助。

内容用于快速浏览;学术引用与结论判断请以英文原文为准。